Microglial TDP-43 Controls Myelin Health and Brain Immune Signaling
A new mouse study reveals that TDP-43 in microglia is essential for myelin maintenance and proper brain immune function — with implications for ALS and dementia.
Summary
Scientists discovered that a protein called TDP-43, already known for its role in ALS and frontotemporal dementia, plays a critical role inside microglia — the brain's resident immune cells. When TDP-43 was removed from microglia in mice, the animals developed abnormal myelin (the protective sheath around nerve fibers), showed signs of dysfunctional immune signaling, and eventually exhibited motor problems as adults. The loss of TDP-43 also disrupted a key immune pathway called TREM2-DAP12, which is important for how microglia recognize and clear damaged material in the brain. This research opens a new angle on why TDP-43 malfunction is so damaging in neurodegenerative diseases, and suggests that glial cells — not just neurons — may be central players in that damage.
Detailed Summary
TDP-43 is a protein infamous for its role in neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In these conditions, TDP-43 mislocalizes — leaving the nucleus and forming toxic clumps in the cytoplasm. While research has focused primarily on neurons, this new study from the University of Lausanne and collaborators asks a different question: what happens when microglia lose TDP-43 function?
Microglia are the brain's immune sentinels, responsible for clearing cellular debris, shaping neural circuits, and maintaining myelin — the fatty insulation around nerve fibers. Using a mouse model in which TDP-43 was selectively knocked out in microglia, researchers combined MRI, confocal microscopy, electron microscopy, and spatial transcriptomics to characterize the consequences in extraordinary detail.
The results were striking. Mice lacking microglial TDP-43 showed structural brain changes and myelin abnormalities beginning in early postnatal development. Spatial transcriptomics revealed an elevated interferon-responsive gene signature linked to oligodendrocyte dysfunction — the cells responsible for producing myelin. Adult mice developed motor deficits, suggesting the early myelin disruption had lasting functional consequences.
Mechanistically, the study uncovered two key defects. First, TDP-43-deficient microglia could no longer efficiently engulf and degrade myelin, disrupting the normal refinement process essential for healthy brain wiring. Second, loss of TDP-43 caused aberrant splicing of the Tyrobp gene — a cryptic exon was incorrectly included, producing a truncated, dysfunctional DAP12 protein. DAP12 is the signaling partner of TREM2, a receptor critically involved in microglial responses to neurodegeneration and a major Alzheimer's disease risk gene.
These findings position microglial TDP-43 as a guardian of both myelin integrity and TREM2-DAP12 immune signaling. This previously unrecognized mechanism may help explain why TDP-43 pathology causes such widespread neurological damage — and points toward microglia as a therapeutic target in ALS and FTD.
Key Findings
- Loss of microglial TDP-43 causes myelin abnormalities in early postnatal mouse brains and motor deficits in adults.
- TDP-43-deficient microglia fail to properly engulf and degrade myelin, disrupting normal brain circuit refinement.
- TDP-43 loss triggers cryptic exon inclusion in Tyrobp mRNA, producing a truncated DAP12 protein and disabling TREM2 signaling.
- Spatial transcriptomics revealed an interferon-responsive gene signature linked to oligodendrocyte dysfunction in affected mice.
- Findings implicate microglial — not just neuronal — TDP-43 dysfunction as a driver of neurodegeneration.
Methodology
Researchers used a microglia-specific TDP-43 knockout mouse model and combined MRI, confocal microscopy, and electron microscopy to assess structural and myelin changes. Spatial transcriptomics characterized gene expression alterations across brain regions, and behavioral testing evaluated motor function in adult animals.
Study Limitations
This study was conducted entirely in mice, and it remains uncertain whether the same mechanisms operate in human microglia or in TDP-43 proteinopathy conditions where TDP-43 mislocalizes rather than disappears entirely. The summary is based on the abstract only, as the full text was not available; specific quantitative results and detailed experimental controls could not be assessed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: